journal article·2020-07-28Open access

Nanopore and Nanoparticle Formation with Lipids Undergoing Polymorphic Phase Transitions

Diana Cholakova, Desislava Glushkova, Slavka Tcholakova, Nikolai Denkov

ACS Nano· Volume 14· Issue 7

Abstract

We describe several unexpected phenomena, caused by a solid–solid phase transition (gel-to-crystal) typical for all main classes of lipid substances: phospholipids, triglycerides, diglycerides, alkanes, etc. We discovered that this transition leads to spontaneous formation of a network of nanopores, spreading across the entire lipid structure. These nanopores are spontaneously impregnated (flooded) by water when appropriate surfactants are present, thus fracturing the lipid structure at a nanoscale. As a result, spontaneous disintegration of the lipid into nanoparticles or formation of double emulsions is observed, just by cooling and heating of an initial coarse lipid-in-water dispersion around the lipid melting temperature. The process of nanoparticle formation is effective even after incorporation of medical drugs of high load, up to 50% in the lipid phase. The role of the main governing factors is clarified, the procedure is optimized, and the possibility for its scaling-up to industrially relevant amounts is demonstrated.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Proteins in Food Systems · Phase Equilibria and Thermodynamics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Pharmaceutical Engineering, Faculty of Chemistry and Pharmacy, Sofia University, 1 James Bourchier Avenue, 1164 Sofia, Bulgaria

Funding

European Cooperation in Science and Technology · H2020 European Research Council · Ministry of Education and Science, Bulgaria

References (35)

Show source-provided references
1. 10.1016/S0169-409X(01)00105-310.1016/S0169-409X(01)00105-3 ↗
2. 10.1021/nn900002m10.1021/nn900002m ↗
3. 10.1016/j.chemphyslip.2014.03.00610.1016/j.chemphyslip.2014.03.006 ↗
4. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
5. 10.2174/15701631179679906210.2174/157016311796799062 ↗
6. Wen J. · 2018 · 12110.1002/9781119247159.ch5 ↗
7. 10.1080/10408398.2011.55955810.1080/10408398.2011.559558 ↗
8. 10.1039/C5SM02958A10.1039/C5SM02958A ↗
9. 10.1016/j.addr.2007.04.01210.1016/j.addr.2007.04.012 ↗
10. 10.1016/j.cofs.2019.11.00610.1016/j.cofs.2019.11.006 ↗
11. 10.1016/j.jff.2019.10373210.1016/j.jff.2019.103732 ↗
12. 10.1016/j.addr.2010.12.00710.1016/j.addr.2010.12.007 ↗
13. Walstra P. · 1998 · 5610.1039/9781847551474-00056 ↗
14. 10.1016/j.ijpharm.2004.07.01710.1016/j.ijpharm.2004.07.017 ↗
15. 10.1007/s11746-011-1882-010.1007/s11746-011-1882-0 ↗
16. 10.1016/0378-5173(95)04286-510.1016/0378-5173(95)04286-5 ↗
17. 10.1016/j.jcis.2016.10.09310.1016/j.jcis.2016.10.093 ↗
18. 10.1016/j.ejpb.2013.04.02010.1016/j.ejpb.2013.04.020 ↗
19. 10.1021/la203474b10.1021/la203474b ↗
20. 10.1016/S0927-7757(02)00167-X10.1016/S0927-7757(02)00167-X ↗
21. Small D. M. · 1986
22. 10.1021/cg025594r10.1021/cg025594r ↗
23. Motoyama M. · Bull. NARO Inst. Livest Grassl Sci. · 2012 · 12 · 19
24. 10.1007/BF0254063010.1007/BF02540630 ↗
25. 10.1021/cg300901v10.1021/cg300901v ↗
26. 10.1007/s11483-014-9365-010.1007/s11483-014-9365-0 ↗
27. 10.1007/s11746-013-2294-010.1007/s11746-013-2294-0 ↗
28. 10.1016/j.colsurfa.2011.12.05610.1016/j.colsurfa.2011.12.056 ↗
29. Sato K. · 201810.1002/9781118593882 ↗
30. 10.1021/la034411f10.1021/la034411f ↗
31. 10.1039/b715933c10.1039/b715933c ↗
32. 10.3892/ol.2016.542110.3892/ol.2016.5421 ↗
33. 10.1021/bm301661w10.1021/bm301661w ↗
34. 10.1081/DDC-12000284710.1081/DDC-120002847 ↗
35. 10.1021/nl900031y10.1021/nl900031y ↗